Strides Pharma Science Limited has informed the Exchange regarding a press release dated May 03, 2023, titled "Strides and Orbicular enter into a strategic partnership to jointly develop a range of nasal sprays".
Press Release May 03 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release Feb 24 2023
- Earnings Update_Q2FY23
- Earnings Update_Q3FY23
- Press Release Jan 20 2023
- Press Release Jan 18 2023
Later from Strides Pharma Science
- Strides Pharma Science Ltd Press Release May 19 2023
- Press Release May 25 2023
- Press Release Jul 04 2023
- Intimation of Board Meeting scheduled on August 2, 2023
- Press Release Aug 02 2023
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science